Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in LCTX held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | BROADWOOD CAPITAL INC | 49.6M | $78.3M | 0.0% | 19.880% | 5.52% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 8.3M | $13.1M | β | 3.337% | 0.00% |
| 3 | Defender Capital, LLC. | 6.7M | $10.6M | -1.5% | 2.699% | 3.77% |
| 4 | MILLENNIUM MANAGEMENT LLC | 5.6M | $8.8M | +163.5% | 2.231% | 0.01% |
| 5 | RAFFLES ASSOCIATES LP | 5.4M | $8.5M | 0.0% | 2.151% | 7.35% |
| 6 | FIFTH THIRD BANCORP | 4.6M | $7.3M | β | 1.845% | 0.01% |
| 7 | BlackRock, Inc. | 3.9M | $6.1M | +0.8% | 1.550% | 0.00% |
| 8 | ARMISTICE CAPITAL, LLC | 3.2M | $5.0M | β | 1.277% | 0.15% |
| 9 | MARSHALL WACE, LLP | 3.1M | $4.8M | +125.0% | 1.230% | 0.01% |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 2.5M | $4.0M | +2.5% | 1.012% | 0.00% |
| 11 | RENAISSANCE TECHNOLOGIES LLC | 2.1M | $3.4M | -11.6% | 0.852% | 0.01% |
| 12 | MORGAN STANLEY | 1.9M | $3.0M | -6.5% | 0.749% | 0.00% |
| 13 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1.4M | $2.2M | +73.5% | 0.564% | 0.00% |
| 14 | UBS Group AG | 1.4M | $2.2M | +648.4% | 0.550% | 0.00% |
| 15 | VANGUARD FIDUCIARY TRUST CO | 1.3M | $2.1M | β | 0.531% | 0.00% |
| 16 | GOLDMAN SACHS GROUP INC | 1.2M | $1.8M | -18.7% | 0.469% | 0.00% |
| 17 | STATE STREET CORP | 1.1M | $1.7M | +7.3% | 0.437% | 0.00% |
| 18 | JANE STREET GROUP, LLC | 993K | $1.6M | -1.1% | 0.398% | 0.01% |
| 19 | RED CRANE WEALTH MANAGEMENT, LLC | 597K | $944K | 0.0% | 0.240% | 0.78% |
| 20 | NORTHERN TRUST CORP | 499K | $789K | +4.1% | 0.200% | 0.00% |
| 21 | SEI INVESTMENTS CO | 422K | $667K | +56.8% | 0.169% | 0.00% |
| 22 | BANK OF AMERICA CORP /DE/ | 419K | $663K | +112.0% | 0.168% | 0.00% |
| 23 | BARCLAYS PLC | 393K | $621K | +12.8% | 0.158% | 0.00% |
| 24 | EAM Investors, LLC | 347K | $548K | -21.6% | 0.139% | 0.06% |
| 25 | Point72 Asset Management, L.P. | 304K | $481K | +90.9% | 0.122% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in LCTX β a direct measure of their conviction.
Filings activity in LCTX during Q1 2026, grouped by how each filer changed its position.
Institutions that opened a new LCTX position in Q1 2026
Institutions that fully closed their LCTX position in Q1 2026
8 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 127 | +4.1% | 55.44% | +0.00 pp | $176M | +0.0% |
| Q4 2025 | 122 | +12% | 55.44% | +8.80 pp | $176M | +19% |
| Q3 2025 | 109 | 17% | 46.64% | +16.39 pp | $148M | +54% |
| Q2 2025 | 131 | +3.1% | 30.25% | +14.72 pp | $96M | +95% |
| Q1 2025 | 127 | +2.4% | 15.53% | 1.30 pp | $49M | 7.7% |
| Q4 2024 | 124 | +9.7% | 16.83% | 9.57 pp | $53M | 36% |
| Q3 2024 | 113 | +0.0% | 26.40% | 3.10 pp | $84M | 11% |
| Q2 2024 | 113 | β | 29.50% | β | $93M | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying LCTX stock.
Based on Q1 2026 13F filings, institutional ownership of Lineage Cell Therapeutics, Inc. stands at 55.4%, held across 127 reporting institutions.
BROADWOOD CAPITAL INC is the largest reported institutional holder of LCTX, with approximately 49,560,992 shares worth $0.08B as of Q1 2026.
Yes β 5 widely-followed marquee investors appear among the top 25 institutional holders of LCTX, including MILLENNIUM MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, JANE STREET GROUP, LLC, Point72 Asset Management, L.P..
Our composite Smart Money Score for LCTX is 69 out of 100 (Bullish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
24 institutions opened new positions in LCTX during Q1 2026, while 19 fully exited. 28 added to existing positions and 72 trimmed.
LCTX institutional ownership rose by 0.00 percentage points quarter-over-quarter, with a net change of +5 holders.
The top 10 institutions account for 83.5% of all reported 13F value in LCTX, and the top 25 account for 96.4%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Lineage Cell Therapeutics, Inc. (LCTX) Institutional Ownership